Top Markets
Coin of the day
Hemostemix Inc. Hemostemix Inc.

Hemostemix Inc.

HEM
Rank in Stocks #32153
Hemostemix Inc., a clinical stage biotechnology company, develops,... Hemostemix Inc., a clinical stage biotechnology company, develops, manufactures, and commercializes blood-derived stem cell therapies for medical conditions in Canada. Its lead product is ACP-01, which is in Phase II clinical trial for the treatment of vascular diseases, such as peripheral arterial disease, angina pectoris, and ischemia, as well as heart failure, ischemic and dilated cardiomyopathy, chronic limb threatening ischemia, vascular dementia, and brain function. The company also develops NCP-01, which is preclinical trial to evaluate effect on neuropathic pain and motor function recovery. Hemostemix Inc. is headquartered in Calgary, Canada.
Share Price
$0.05504527
Last synced: 2026-08-17
Market Cap
$10.89M
Change (1 day)
15.38%
Change (1 year)
-10.64%
Country
CA
Trade Hemostemix Inc. (HEM)

Category

Stock split history for Hemostemix Inc. (HEM)
Hemostemix Inc. stock (symbol: HEM) underwent a total of 0 stock splits.
The most recent stock split occurred on Aug 18, 2026.
One HEM share bought prior to Aug 18, 2026 would equal to 0 HEM shares today.
Stock split list
Year Split Multiple Cumulative Multiple
Not enough data for the provided dates.
Stock splits for similar companies or competitors
Company Number of stock splits Cumulative Multiple Country
1 x2
US
0 -
NL
1 x3
AU
0 -
CH
0 -
KR